Sapporo, Japan

Takashi Arima

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Arima. Retrieved from https://idiyas.com/inventor/takashi-arima-xd6k7uso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Arima: Innovator in Bicyclolactam Compounds

Introduction

Takashi Arima is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on bicyclolactam compounds. His research focuses on developing compounds that exhibit anxiolytic effects while minimizing side effects.

Latest Patents

Takashi Arima holds a patent for a bicyclolactam compound, which is described as having an excellent anxiolytic effect. This compound is recognized for its high safety profile and is useful as an effective component in medicinals that significantly reduce side effects such as hypnotic, muscle relaxant, and sedative effects. He has 1 patent to his name, showcasing his dedication to advancing medicinal chemistry.

Career Highlights

Throughout his career, Takashi Arima has demonstrated a commitment to innovation in the pharmaceutical industry. His work has contributed to the development of safer and more effective medicinal compounds, which can greatly benefit patients in need of anxiolytic treatments.

Collaborations

Takashi has collaborated with notable colleagues, including Masato Nanri and Ichiro Yamawaki. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

In summary, Takashi Arima is a distinguished inventor whose work on bicyclolactam compounds has the potential to transform the landscape of anxiolytic medications. His innovative approach and dedication to safety in medicinal chemistry are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…